Table 1 The primary and secondary antibodies used in this study
From: Effects of early local administration of high-dose bFGF on a recurrent laryngeal nerve injury model
Antibody | Source | Catalog No | Host | Type | Dilution |
|---|---|---|---|---|---|
Primary antibody | |||||
Ki-67 | Novus Biologicals(Centennial, CO, USA) | NB600-1252 | Rabbit | Monoclonal | 1:300 |
Pax7 | Santa Cruz Biotechnology(Santa Cruz, CA, USA) | sc-81975 | Mouse | Monoclonal | 1:300 |
MyoD | Dako (Tokyo, Japan) | M3512 | Mouse | Monoclonal | 1:300 |
synaptophisin | Gene Tex (Irvine, CA, USA) | GTX633821 | Mouse | Monoclonal | 1:200 |
CHRNB1 | Thermo Fisher Scientific (Waltham, MA, USA) | PA5-76704 | Rabbit | Polyclonal | 1:200 |
Secondary antibody | |||||
Anti-rabbit IgG (Alexa Fluor® 488) | Abcam (Cambridge, MA, USA) | ab150077 | Goat | Polycolonal | 1:500 |
Anti-mouse IgG (Alexa Fluor® 568) | Abcam (Cambridge, MA, USA) | ab175473 | Goat | Polycolonal | 1:500 |